Selaus asiasanan mukaan kokoelmassa Åbo Akademi

    • Development of Novel Drugs Targeting Chaperones of Oncogenic K-Ras 

      Siddiqui, Farid Ahmad (Åbo Akademi - Åbo Akademi University, 12.02.2021)
      KRAS mutations account globally for about one million deaths per year, but there is as yet no approved drug against KRAS. K-Ras proteins are organized into di-/oligomeric nanoscale signaling complexes, known as nanoclusters ...